A randomized, controlled trial to determine if continuing ribavirin (RVN) as monotherapy following interferon/ribavirin (IFN/RVN) combination therapy will increase sustained virologic response in patients with chronic HCV
Hofmann, Charlotte M., Sterling, Richard K., Luketic, Velimir A., Sanyal, Arun J., Shiffman, Mitchell L.Volume:
118
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(00)85927-2
Date:
April, 2000
File:
PDF, 191 KB
english, 2000